Entered Agreement with WealthBlock

Reverb Medical Inc, a Delaware corporation headquartered in Del Mar, CA, announced today that it has launched a $2.5M Reg D 506(c) SAFE series seed private placement round and has entered into an agreement with WealthBlock, Inc., a leader in digital securities. The use of proceeds will allow Reverb Medical to further develop its medical device technology and create a pathway to file its 510(k) application with the FDA.

"This private placement and partnership with WealthBlock will allow us to accelerate the development of our medical device technology and bring our products to market sooner," said Richard Simpson, CEO of Reverb Medical. "We are excited to be working with WealthBlock to create a digital security that will provide our investors with a new and innovative way to invest in our company."

Reverb Medical's technology is based on a proprietary platform that uses Motion Activated Systems to creates the movement of biological fluids and patency within the patient’s chest tubes after cardiac surgery. The company's products are designed to improve the accuracy and efficiency of medical diagnosis and treatment.